(MENAFN- GlobeNewsWire - Nasdaq) The report identifies opportunities in optimizing Basal Cell Carcinoma clinical trials through strategic location selection, understanding enrollment trends, and evaluating trial success rates. It emphasizes leveraging global and regional insights for effective investment and competitive strategy development.

Dublin, Nov. 05, 2025 (GLOBE NEWSWIRE) -- The "Basal Cell Carcinoma (Basal Cell Epithelioma) - Global Clinical Trials Review, 2025" clinical trials has been added to ResearchAndMarkets's offering.
The clinical trial report provides top line data relating to the clinical trials on Basal Cell Carcinoma (Basal Cell Epithelioma). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type.

Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). The analyst Clinical Trial Reports are generated using the analyst's proprietary database - Pharma - Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
Scope

• The report provides a snapshot of the global clinical trials landscape
• Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
• The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
• The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
• The Report provides enrollment trends for the past five years
• Report provides latest news for the past three months

Reasons to Buy

• Assists in formulating key business strategies with regards to investment
• Helps in identifying prominent locations for conducting clinical trials which saves time and cost
• Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
• Supports understanding of trials count and enrollment trends by country in global therapeutics market
• Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
• Facilitates clinical trial assessment of the indication on a global, regional and country level

Key Topics Covered:

• Report Guidance
• The analyst Clinical Trials Report Coverage
• Clinical Trials by Region
• Clinical Trials and Average Enrollment by Country
• Top Five Countries Contributing to Clinical Trials in Asia-Pacific
• Top Five Countries Contributing to Clinical Trials in Europe
• Top Countries Contributing to Clinical Trials in North America
• Top Five Countries Contributing to Clinical Trials in Middle East and Africa
• Top Five Countries Contributing to Clinical Trials in Central and South America
• Clinical Trials by G7 Countries: Proportion of Basal Cell Carcinoma (Basal Cell Epithelioma) to Oncology Clinical Trials
• Clinical Trials by Phase in G7 Countries
• Clinical Trials in G7 Countries by Trial Status
• Clinical Trials by E7 Countries: Proportion of Basal Cell Carcinoma (Basal Cell Epithelioma) to Oncology Clinical Trials
• Clinical Trials by Phase in E7 Countries
• Clinical Trials in E7 Countries by Trial Status
• Clinical Trials by Phase
• In Progress Trials by Phase
• Clinical Trials by Trial Status
• Clinical Trials by End Point Status
• Subjects Recruited Over a Period of Time
• Clinical Trials by Sponsor Type
• Prominent Sponsors
• Top Companies Participating in Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials
• Prominent Drugs
• Latest Clinical Trials News on Basal Cell Carcinoma (Basal Cell Epithelioma)
• Sep 08, 2025: Medicus Pharma Provides Update on United Arab Emirates (UAE) SKNJCT-004 Phase 2 Clinical Study to Non-Invasively Treat BCC
• Aug 21, 2025: Medicus Provides Update on Doxorubicin Containing Novel Microneedle Array Clinical Development Program for the Treatment of BCC of the Skin
• Jul 08, 2025: Medicus Pharma Announces Submission of Type C Meeting Request to the Food and Drug Administration (FDA)
• Clinical Trial Profile Snapshots
• Abbreviations

Companies Featured

• Novartis AG
• Bristol-Myers Squibb Co
• Roche Holding AG
• Eli Lilly and Co
• Galderma SA
• Regeneron Pharmaceuticals Inc
• Sun Pharmaceutical Industries Ltd
• Viatris Inc
• Merck & Co Inc
• Ascend Biopharmaceuticals Ltd

For more information about this clinical trials report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: Laura Wood,Senior Press Manager... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN05112025004107003653ID1110300263